https://dengyuemed.com/news/innovative-lung-cancer-drug-asandeutertinib/
Innovative Lung Cancer Drug Asandeutertinib Approved In China
Sep 18, 2026 - Learn about innovative lung cancer drug asandeutertinib, its NMPA approval, mechanism, CNS metastases indication, and key ESAONA clinical data.
lung cancerin chinainnovativedrugasandeutertinib